Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment

Merck& Co. ’s immunotherapy cancer drug Keytruda received U.S. Food and Drug Administration approval as a first-line treatment for certain lung cancer patients.

Source: WSJ.com: Health - October 25, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news